Article 1
Open ↗Annexes I and II to Decision 2008/911/EC are amended in accordance with the Annex to this Decision.
Source
Commission Implementing Decision (EU) 2022/1316 of 25 July 2022 amending Decision 2008/911/EC establishing a list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products (notified under document C(2022) 4341)
Commission Implementing Decision (EU) 2022/1316 of 25 July 2022 amending Decision 2008/911/EC establishing a list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products (notified under document C(2022) 4341)
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
Article 2
Open ↗The Decision is addressed to the Member States.
Supplementary provisions
ANNEXSupplementary provisions
Open ↗ANNEX Annexes I and II to Decision 2008/911/EC are amended as follows: (1) In Annex I, the following substance is inserted before Calendula officinalis L: ‘ Achillea millefolium L., herba (Yarrow)’ (2) In Annex II, the following is inserted before ‘COMMUNITY LIST ENTRY ON CALENDULA OFFICINALIS L ’ : ‘ UNION LIST ENTRY ON ACHILLEA MILLEFOLIUM L., HERBA Scientific name of the plant Achillea millefolium L. Botanical family Asteraceae Herbal substance Millefolii herba Common name in all EU official languages of herbal substance BG (bulgarski): Бял равнец, стрък CS (čeština): Řebříčková nať DA (dansk): Røllike DE (deutsch): Schafgarbenkraut EL (elliniká): Πόα αχιλλείας EN (English): yarrow ES (español): Milenrama, sumidades floridas de ET (eesti keel): Raudrohuürt FI (suomi): siankärsämö, verso FR (français): Achillée millefeuille (parties aériennes d’) GA (Gaeilge): Athair thalún HR (hrvatski): Stolisnikova zelen HU (magyar): Közönséges cickafark virágos hajtás IT (italiano): Achillea millefoglie parti aeree LT (lietuvių kalba): Kraujažolių žolė LV (latviešu valoda): Pelašķu laksti MT (Malti): Ħaxixa tal-morliti NL (Nederlands): Duizendblad PL (polski): Ziele krwawnika PT (português): Milefólio RO (română): Iarbă de coada şoricelului SK (slovenčina): Vňať rebríčka SL (slovenščina): Zel navadnega rmana SV (svenska): Rölleka, ört IS (íslenska): NO (norsk): Ryllik Herbal preparation(s) Comminuted herbal substance Dry extract (DER 6-9:1), extraction solvent water Dry extract (DER 5-10:1), extraction solvent water European Pharmacopoeia monograph reference Yarrow – Millefolii herba (07/2014:1382) Indications Indication (1) Traditional herbal medicinal product used for temporary loss of appetite. Indication (2) Traditional herbal medicinal product for the symptomatic treatment of mild, spasmodic gastrointestinal complaints including bloating and flatulence. Indication (3) Traditional herbal medicinal product for the symptomatic treatment of minor spasm associated with menstrual periods. Indication (4) Traditional herbal medicinal product for treatment of small superficial wounds. The product is a traditional herbal medicinal product for use in specified indications exclusively based upon long-standing use. Type of tradition European Specified strength Please see ‘Specified posology’. Specified posology Adolescents, adults and elderly Single dose Indications (1) and (2) Herbal tea: 1,5-4 g of the comminuted herbal substance in 150-250 ml of boiling water as a herbal infusion 3-4 times daily between meals. Daily dose: 4,5 to 16 g For indication (1), the liquid preparations are to be taken 30 minutes before meals. Indication (2) Dry extract (DER 6-9:1), extraction solvent water: 334 mg dry extract 3-4 times daily. Daily dose: 1,002-1,336 g Indication (3) Herbal tea: 1-2 g of the comminuted herbal substance in 250 ml of boiling water as a herbal infusion 2-3 times daily. Daily dose: 2-6 g Dry extract (DER 5-10:1), extraction solvent water: 250 mg dry extract 2-3 times daily. Daily dose: 0,50-0,75 g Indication (4) Comminuted herbal substance for infusion preparation for cutaneous use: 3-4 g of the comminuted herbal substance in 250 ml of boiling water 2-3 times daily. Daily dose: 6-12 g The use in children under 12 years of age is not recommended (see section ‘Special warnings and precautions for use’). Route of administration Indications (1), (2) and (3) Oral use. Indication (4) Cutaneous use: to be applied as an impregnated dressing to the affected area. Duration of use or any restrictions on the duration of use Indications (1) and (2) If the symptoms persist longer than 2 weeks during the use of the medicinal product, a doctor or a qualified health care practitioner should be consulted. Indications (3) and (4) If the symptoms persist longer than 1 week during the use of the medicinal product, a doctor or a qualified health care practitioner should be consulted. Any other information necessary for the safe use Contraindications Hypersensitivity to the active substances and to other plants of the Asteraceae ( Compositae ) family. Special warnings and precautions for use The use in children under 12 years of age has not been established due to lack of adequate data. Indications (1), (2) and (3) If the symptoms worsen during the use of the medicinal product, a doctor or a qualified health care practitioner should be consulted. Indication (4) If signs of skin infection are observed, medical advice should be sought. Interactions with other medicinal products and other forms of interaction None reported. Fertility, pregnancy and lactation Safety during pregnancy and lactation has not been established. In the absence of sufficient data, the use during pregnancy and lactation is not recommended. No fertility data available. Effects on ability to drive and use machines No studies on the effect on the ability to drive and use machines have been performed. Undesirable effects Hypersensitivity reactions of the skin have been reported. The frequency is not known. If other adverse reactions not mentioned above occur, a doctor or a qualified health care practitioner should be consulted. Overdose No case of overdose has been reported. Pharmaceutical particulars Not applicable Pharmacological effects or efficacy plausible on the basis of long-standing use and experience. Not applicable.’
Other acts of the same type
2009/757/EC: Commission Decision of 14 October 2009 on the extension of the mandate of the European Group on Ethics in Science and New Technologies and of the period of appointment of its members2009/755/EC: Commission Decision of 13 October 2009 concerning the adoption of a financing decision towards a preparatory action on control posts for 20092009/770/EC: Commission Decision of 13 October 2009 establishing standard reporting formats for presenting the monitoring results of the deliberate release into the environment of genetically modified organisms, as or in products, for the purpose of placing on the market, pursuant to Directive 2001/18/EC of the European Parliament and of the Council (notified under document C(2009) 7680) (Text with EEA relevance)2009/826/EC: Commission Decision of 13 October 2009 authorising the placing on the market of a leaf extract from Lucerne ( Medicago sativa ) as novel food or novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2009) 7641)2009/827/EC: Commission Decision of 13 October 2009 authorising the placing on the market of Chia seed ( Salvia hispanica ) as novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2009) 7645)2009/751/EC: Commission Decision of 12 October 2009 amending the Appendix to Annex VI to the Act of Accession of Bulgaria and Romania as regards certain milk-processing establishments in Bulgaria (notified under document C(2009) 7637) (Text with EEA relevance)2009/752/EC: Commission Decision of 12 October 2009 authorising the placing on the market of a lipid extract from Antarctic Krill Euphausia superba as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2009) 7647)2009/746/EC: Commission Decision of 9 October 2009 on a Community financial contribution towards Member States’ fisheries control, inspection and surveillance programmes for 2009 (notified under document C(2009) 7592)2009/748/EC: Council Decision of 9 October 2009 regarding the position to be taken by the Community within the International Jute Study Group Council on extension of the Agreement establishing the Terms of Reference of the International Jute Study Group, 20012009/756/EC: Commission Decision of 9 October 2009 laying down specifications for the resolution and use of fingerprints for biometric identification and verification in the Visa Information System (notified under document C(2009) 7435)2009/804/EC: Council Decision of 9 October 2009 revoking the agreements between the European Coal and Steel Community and the Swiss ConfederationCouncil Decision of 9 October 2009 on the signing and conclusion of the Agreement in the form of an Exchange of Letters between the European Community and the Arab Republic of Egypt concerning reciprocal liberalisation measures on agricultural products, processed agricultural products and fish and fishery products, the replacement of Protocols 1 and 2 and their annexes and amendments to the Euro-Mediterranean Agreement establishing an association between the European Communities and their Member States, of the one part, and the Arab Republic of Egypt, of the other part
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.
What to look at next
Browse all EU Legal ActsEvery instrument by type and year, full text free to read section by sectionEuropean Union legislationEU Legal Acts by type and yearGrouped by instrument type and year of enactment, so you can find others of the same kindBrowse by type and yearEuropean Union: what this database coversWhich datasets are here, which official source they come from, and how current they areEuropean Union overview